Skip to main content
logo
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
13.35
-0.59 (-4.23%)
At close: Jul 10, 2026, 4:00 PM EDT
13.50
+0.15 (1.12%)
After-hours: Jul 10, 2026, 7:57 PM EDT

Zevra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
789509448272159305
Market Cap Growth
54.68%13.81%64.53%71.60%-48.00%499.98%
Enterprise Value
589.72381.61438.41248.0889.82194.14
Last Close Price
13.358.968.346.554.598.71
PE Ratio
6.736.64----
Forward PE
23.9819.15----
PS Ratio
6.454.7818.969.9115.1610.64
PB Ratio
3.833.2911.284.392.112.40
P/TBV Ratio
3.963.58--2.112.04
P/FCF Ratio
65.79----29.50
P/OCF Ratio
61.82----29.21
EV/Sales Ratio
4.823.5818.579.038.596.78
EV/EBITDA Ratio
46.31----24.31
EV/EBIT Ratio
59.20----25.12
EV/FCF Ratio
49.16----18.78
Debt / Equity Ratio
0.000.411.510.700.180.01
Debt / EBITDA Ratio
0.17----0.20
Debt / FCF Ratio
0.10----0.15
Net Debt / Equity Ratio
-0.97-0.83-0.23-0.39-0.92-0.87
Net Debt / EBITDA Ratio
-28.842.170.110.491.65-13.87
Net Debt / FCF Ratio
-16.6352.530.130.713.65-10.71
Asset Turnover
0.430.460.130.190.080.40
Inventory Turnover
8.418.897.53---
Quick Ratio
4.745.462.351.157.5826.92
Current Ratio
4.895.682.531.187.7227.20
Return on Equity (ROE)
41.15%85.66%-207.75%-67.27%-41.11%-28.18%
Return on Assets (ROA)
1.65%-28.28%-41.18%-34.49%-34.88%10.68%
Return on Invested Capital (ROIC)
27.99%-228.37%-211.01%-224.36%-382.41%76.85%
Return on Capital Employed (ROCE)
1.74%-32.32%-71.71%-49.13%-36.64%11.68%
Earnings Yield
14.83%15.07%----
FCF Yield
1.52%----3.39%
Buyback Yield / Dilution
-19.19%-23.81%-30.46%-2.79%-15.87%-647.71%
Total Shareholder Return
-19.19%-23.81%-30.46%-2.79%-15.87%-647.71%
SEC Filings: 10-K · 10-Q